Market stays up for 3rd day, earnings numbers loom

Image
Press Trust of India Mumbai
Last Updated : Oct 10 2017 | 5:13 PM IST
Stocks today pushed ahead for the third straight day -- eyes firmly on upcoming corporate earnings -- with the Sensex hitting nearly three-week high and the Nifty pulling off 10,000 again.
The gains were on a tight leash as investors tried to cushion their exposure ahead of the corporate results, which serve as a barometer to find out if the recent market rally is in keeping with its fundamentals.
The July-September quarterly results are going to formally kick off with TCS, which is set to announce its numbers on Thursday. Reliance Industries is lined up next.
Driven by pharma, oil and gas and banking stocks, the Sensex ended at 31,924.41, up 77.52 points -- or 0.24 per cent. This is its highest closing since September 21 when it read 32,370.04.
The gauge had climbed 254.86 points in the previous two days.
For the 50-share NSE Nifty, the close came in at 10,016.95, higher by 28.20 points, or 0.28 per cent, after shuttling between 10,034 and 10,002.30.
"Main indices traded on a positive note, but investors' cautious view on valuation and upcoming earnings season influenced profit booking on every rise. But mid and small cap attracted investor attention led by ease in GST rates and stock-specific actions while pharma gained after a series of approvals from the USFDA," said Vinod Nair, Head of Research, Geojit Financial Services Ltd.
Domestic financial institutions continued to hold ground and retail investors built up more bets amid a firming Asian trend, said analysts. Domestic institutional investors (DIIs) net picked up shares worth Rs 55.42 crore yesterday. Foreign portfolio investors (FPIs) exited, net pulling out shares amounting to Rs 475.11 crore, showed provisional data.
IT, power, capital goods and auto sectors were other major winners of the day.
Key European indices trended down early on.
Drugmaker Lupin topped the Sensex list by surging 1.99 per cent to Rs 1,060.50 after the US Food and Drug Administration approved its generic drug to treat hypertension.
India's second-largest IT firm Infosys went up 1.29 per cent to Rs 935.60 after the company said it has fixed November 1, 2017, as the record date for its share buyback programme.
Other big movers were PowerGrid, Axis Bank, RIL and Coal India.
As for sectoral indices, utilities took the lead, followed by energy.
Broader markets such as small-cap and mid-cap indices left the key indices behind, surging up to 0.95 per cent.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 10 2017 | 5:13 PM IST

Next Story